1-ethyl-3-(3-ethylsulfinylcyclohexyl)-2-[(3-methylthiophen-2-yl)methyl]guanidine
C17H29N3OS2 — CID 109438585
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-ethyl-3-(3-ethylsulfinylcyclohexyl)-2-[(3-methylthiophen-2-yl)methyl]guanidine
1-ethyl-3-(3-ethylsulfinylcyclohexyl)-2-[(3-methylthiophen-2-yl)methyl]guanidine (PubChem CID 109438585) has the molecular formula C17H29N3OS2 and a molecular weight of 355.57 g/mol. Its IUPAC name is 1-ethyl-3-(3-ethylsulfinylcyclohexyl)-2-[(3-methylthiophen-2-yl)methyl]guanidine.
Molecular Properties
| Compound Name | 1-ethyl-3-(3-ethylsulfinylcyclohexyl)-2-[(3-methylthiophen-2-yl)methyl]guanidine |
|---|---|
| PubChem CID | 109438585 |
| Molecular Formula | C17H29N3OS2 |
| Molecular Weight | 355.57 g/mol |
| Exact Mass | 355.18 |
| IUPAC Name | 1-ethyl-3-(3-ethylsulfinylcyclohexyl)-2-[(3-methylthiophen-2-yl)methyl]guanidine |
| SMILES | CCN/C(=N\Cc1sccc1C)NC1CCCC(S(=O)CC)C1 |
| InChI | InChI=1S/C17H29N3OS2/c1-4-18-17(19-12-16-13(3)9-10-22-16)20-14-7-6-8-15(11-14)23(21)5-2/h9-10,14-15H,4-8,11-12H2,1-3H3,(H2,18,19,20) |
| InChIKey | VYPACANFBGWQQJ-UHFFFAOYSA-N |
| XLogP | 3.19 |
| TPSA | 53.49 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 355.57 |
| LogP ≤ 5 | 3.19 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 109438585 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.